Poloxamers Have Vaccine-Adjuvant Properties by Increasing Dissemination of Particulate Antigen at Distant Lymph Nodes

Vaccine technology is still facing challenges regarding some infectious diseases, which can be addressed by innovative drug delivery systems. In particular, nanoparticle-based vaccines combined with new types of adjuvants are actively explored as a platform for improving the efficacy and durability...

Descripción completa

Detalles Bibliográficos
Autores principales: Lamrayah, Myriam, Phelip, Capucine, Rovera, Renaud, Coiffier, Céline, Lazhar, Nora, Bartolomei, Francesca, Colomb, Evelyne, Verrier, Bernard, Monge, Claire, Richard, Sophie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304813/
https://www.ncbi.nlm.nih.gov/pubmed/37375333
http://dx.doi.org/10.3390/molecules28124778

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304813/
https://www.ncbi.nlm.nih.gov/pubmed/37375333
http://dx.doi.org/10.3390/molecules28124778

Ejemplares similares